LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell ...
Technological advancements can address the formulation and dissolution challenges of HPMC polymers. Editor’s Note: A version of this article was published in Pharmaceutical Technology Europe’s APIs, ...
Innovations in hard-capsule technology enhance the flexibility that hard capsules can provide for dosage forms. The pharmaceutical industry is at the forefront of innovation, helping people to live ...
Homogeneous molecular catalysts are highly active and selective as they possess well-tailored structures and accessible sites. Unfortunately, the difficulty related to catalyst recovery impedes their ...
Hubei Kornnac Pharmaceutical Co., Ltd. continues to strengthen its reputation as a leading manufacturer in the pharmaceutical capsule industry, responding to growing international demand for advanced ...
PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner, said, “We have completed another study that proves exactly what we expected to find in the data. Like previous biocompatibility studies on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results